KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Asset Writedowns and Impairment (2016 - 2025)

Sabra Health Care REIT (SBRA) has 12 years of Asset Writedowns and Impairment data on record, last reported at $5.0 million in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 126.14% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $7.3 million, up 1382.31%, while the annual FY2025 figure was $7.3 million, 1382.31% up from the prior year.
  • Asset Writedowns and Impairment reached $5.0 million in Q4 2025 per SBRA's latest filing, up from $2.6 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $21.4 million in Q4 2022 and bottomed at -$19.0 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $3.3 million, with a median of $495000.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 1387.16% in 2023, then plummeted 5219.27% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $9.0 million in 2021, then surged by 138.14% to $21.4 million in 2022, then crashed by 101.67% to -$358000.0 in 2023, then tumbled by 5219.27% to -$19.0 million in 2024, then skyrocketed by 126.14% to $5.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $5.0 million in Q4 2025, $2.6 million in Q3 2025, and -$227000.0 in Q2 2025.